Mv Capital Management, Inc. Jounce Therapeutics, Inc. Transaction History

Mv Capital Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 12, 2021	SELL	$5.04 - $8.73 $2,520 - $4,365	-500 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$4.17 - $7.58 $2,085 - $3,790	500 New	500 $3,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mv Capital Management, Inc. with notifications on news.